Skip to main content
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

First annual report of the EU Member State Coordination Group on HTA (HTACG)

On February 16, 2026, the Member State Coordination Group on HTA (HTACG) released its first annual report, detailing all activities of the group and its subgroups in 2025 within the joint EU-level HTA framework. The framework became fully operational on January 12, 2025, when Regulation (EU) 2021/2282 entered into application, creating a legal basis for Member States' cooperation on joint clinical assessments of medicines and medical devices. 

The key activities HTACG subgroups related to medical devices and in-vitro diagnostics in 2025 included the following:

  • The Joint Clinical Assessments (JCA) subgroup is responsible for developing a draft recommendation to HTACG regarding the selection of medical devices and in-vitro diagnostics (IVDs) for JCA. A pilot on the recommendation process was conducted, providing practical experience with the application of the selection criteria, the timeline, and the development of a template recommendation for the selection of medical devices and IVDs. The first JCA for medical devices and IVDs will start in 2026.
  • The Joint Scientific Consultations (JSC) subgroup opened two request periods for consultations. However, no requests were received from the developers of medical devices or IVDs in 2025.
  • The Emerging Health Technologies (EHT) subgroup conducted horizon scanning and prepared a report on medicines, medical devices, and IVDs that fall within the scope of the HTAR framework and are to be considered for JCA in 2026.
  • The subgroup for the development of methodological and procedural guidance released several guidance documents for JCA and JSC of medical devices and IVDs.

See more details here.

This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.

Tags